Some of Your Wegovy Shot Leaked Out: Here's What It Means

The scenario: you pull the pen away and there's liquid on your skin

Picture it: you've held the pen in place, heard the click, counted to ten, and when you lift it away there's a small bead of fluid sitting on the skin. It's easy to assume the injection failed. In most cases it hasn't. What you're seeing is almost always a tiny amount of solution that tracked back along the needle channel as it withdrew, or that pooled just under the surface because the pen was moved slightly before the plunger finished its stroke.

The Wegovy pre-filled pen delivers the dose subcutaneously, into fatty tissue a few millimetres below the surface. The volume involved is small (around 0.5 ml) and even a visible droplet on the skin typically represents a fraction of that. Correct injection technique matters here more than many people expect: pressing the pen firmly against the skin, keeping it still while the dose delivers, and holding it in place for the full count before lifting all reduce the chance of solution escaping.

If the wet patch was large (genuinely soaking the skin rather than a pinhead-size bead) or if you noticed the pen felt different from usual, that is worth noting. You can read more about what the pen should feel like during a normal injection on our guide to pen leakage after injection.

What to do right now, and what not to do

The first rule is not to re-inject. Even if you suspect most of the dose escaped, administering a second injection to make up for it risks taking far more semaglutide than your body has adjusted to at your current dose level. The side-effect profile of Wegovy is largely gastrointestinal (nausea, diarrhoea, stomach discomfort) and those effects intensify with higher-than-intended exposure. The NHS semaglutide page is clear: if you are unsure what to do after an injection problem, check the Patient Information Leaflet that came with your pen or contact your prescribing service.

Press a clean pad lightly against the site if there is any bleeding, but do not rub, rubbing disperses the solution into a larger surface area and may reduce absorption. Do not apply heat or massage.

Then, note it down. A pattern of leakage on two or three consecutive injections is different from a one-off. If you are using alcohol swabs before each injection, make sure the skin is fully dry before inserting the needle, damp skin can allow surface fluid to accumulate and look like leakage when it isn't. Write down which site you used and whether anything felt unusual; that information is useful if you need to speak to a prescriber.

The technique details that actually prevent leakage

Leakage from the injection site often comes down to a handful of correctable habits. Needle angle is one. The Wegovy pen is designed to inject at 90 degrees (straight in, perpendicular to the skin) and a tilted approach leaves part of the dose shallower than intended, making it easier for fluid to escape. Pinching the skin before injecting, especially on leaner abdomens or thighs, creates a firmer subcutaneous pocket for the fluid to enter.

Site rotation is the other major factor. Injecting into the same small patch week after week causes localised changes to the tissue (small areas of fibrosis) that absorb medication poorly and can push fluid back to the surface. The three recommended sites are the abdomen (avoiding a 5 cm radius around the navel), the outer thigh, and the upper arm. Rotating systematically across these reduces the risk of tissue changes building up.

There is also timing to consider. During a busy week, especially around a bank holiday or a Monday injection being shifted by a day, the injection can end up rushed, standing at the kitchen counter rather than seated and relaxed with the skin properly exposed. What to expect in the early weeks of treatment covers more on building a routine that minimises these small errors. Absorption and tolerability both benefit from consistency.

If technique is correct and leakage keeps happening, the injection site itself may need to move further from areas with more subcutaneous scar tissue. Our page on fluid leaking from the injection site covers the site-selection detail in depth.

When a missed or partial dose genuinely affects your progress

If you are confident that a significant portion of the injection was lost (the pen depressed but did not deliver, or the volume on the skin was substantial) you are effectively in the territory of a missed dose. The MHRA's guidance on GLP-1 medicines does not give patient-level instructions on partial doses; those decisions belong to the prescriber. The standard missed-dose rule for Wegovy (inject as soon as possible if within a certain window; skip it and continue if you're too close to the next scheduled injection) comes from the Patient Information Leaflet, and the window matters, which is why reading it rather than relying on a search result is the right call.

What a missed or partially delivered dose does not usually do is derail progress after one occurrence. The medicine has a long half-life and builds up over weeks of consistent use. One uncertain injection at week four or week twelve is unlikely to undo the trajectory, though a pattern of poor absorption is worth addressing. If you are unsure about what missing a Wegovy injection means for your dose schedule, that page sets out the leaflet-aligned framework clearly.

Questions that go beyond technique (concerns about your dose, your progress, or whether an alternative might suit you better) are exactly what a prescribing consultation is for. At nume, a real clinician reads your consultation the same day; if you'd like that clinical oversight behind your treatment, you can start your free consultation and get a considered answer.